Related Experiment Video
Updated: Jul 11, 2026
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
RETRACTED: MiR-122 Induces Radiosensitization in Non-Small Cell Lung Cancer Cell Line
Debin Ma1, Hui Jia2, Mengmeng Qin3
1Department of Respiratory Diseases, General Hospital of Shenyang Military Command, Shenyang 110016, China. madebin119@163.com.
Abstract:
MiR-122 is a novel tumor suppresser and its expression induces cell cycle arrest, or apoptosis, and inhibits cell proliferation in multiple cancer cells, including non-small cell lung cancer (NSCLC) cells. Radioresistance of cancer cell leads to the major drawback of radiotherapy for NSCLC and the induction of radiosensitization could be a useful strategy to fix this problem. The present work investigates the function of miR-122 in inducing radiosensitization in A549 cell, a type of NSCLC cells. MiR-122 induces the radiosensitization of A549 cells. MiR-122 also boosts the inhibitory activity of ionizing radiation (IR) on cancer cell anchor-independent growth and invasion. Moreover, miR-122 reduced the expression of its targeted genes related to tumor-survival or cellular stress response. These results indicate that miR-122 would be a novel strategy for NSCLC radiation-therapy.
Insights
MicroRNA-122 (miR-122) enhances radiosensitization in non-small cell lung cancer (NSCLC) cells. This microRNA inhibits cancer cell growth and invasion, offering a potential new strategy for NSCLC radiation therapy.
Area of Science:
- Oncology
- Molecular Biology
- Radiotherapy Research
Background:
- Non-small cell lung cancer (NSCLC) exhibits radioresistance, a significant limitation in radiotherapy.
- MicroRNA-122 (miR-122) functions as a tumor suppressor, inhibiting proliferation and inducing apoptosis in various cancer cells.
- Radiosensitization is a critical strategy to improve the efficacy of radiotherapy for NSCLC.
Purpose of the Study:
- To investigate the role of miR-122 in inducing radiosensitization in A549 NSCLC cells.
- To evaluate the effect of miR-122 on the response of NSCLC cells to ionizing radiation (IR).
Main Methods:
- A549 NSCLC cells were treated with miR-122.
- The radiosensitizing effects of miR-122 were assessed following exposure to ionizing radiation (IR).
- Inhibition of cancer cell proliferation, anchor-independent growth, and invasion were measured.
- Expression levels of miR-122 targeted genes involved in tumor survival and stress response were analyzed.
Main Results:
- MiR-122 significantly induced radiosensitization in A549 NSCLC cells.
- MiR-122 enhanced the inhibitory effects of IR on anchor-independent growth and invasion of cancer cells.
- MiR-122 reduced the expression of targeted genes associated with tumor survival and cellular stress response.
Conclusions:
- MiR-122 demonstrates a potent radiosensitizing effect in NSCLC cells.
- MiR-122 holds promise as a novel therapeutic strategy to enhance the effectiveness of radiation therapy for NSCLC.
- Targeting miR-122 could overcome radioresistance and improve treatment outcomes in NSCLC patients.
